GAMALINE®+HIPERICIN® for PMS Treatment and Vasomotor Symptoms

• Status: Unknown status
• Trial end date: 2012-12-01
• Target enrollment: 0
• Participant gender: Female

Summary

2 phytomedicines already in the market: GAMALINE® for premenstrual syndrome and HIPERICIN® as antidepressant will be prescribed together for treating women with Premenstrual Syndrome (PMS) symptoms and vasomotor problems for checking the advantage compared to the GAMALINE® prescription alone.

• Phase: Phase 3
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Phytopharm Consulting Brazil
• Collaborators: Federal University of Health Science of Porto Alegre; Herbarium Laboratorio Botanico Ltda

Criteria

Inclusion Criteria:

• fertile women between 25-44 years old

• climacteric women between 45-55 years old

Exclusion Criteria:

• inferior age to 25 years old

• superior age to 55 years old

• post-menopausal

• under hormone therapy

• thyroid disease

• under psychiatric therapy or medication

• history for allergies and/or hypersensitivity to any component

• breast feeding or pregnancy

• no knowledge for writing and/or reading